GLAND PHARMA
Gland Pharma stock rallies 7%, up 47 % over issue priceThe stock was listed on November 20, and since then has ended lower in one session.
- Gland Pharma up 40% in 2 days, but nobody can explain this sudden interest
Runjhun Jain, a pharma analyst from Nirmal Bang, said the surge could only be a short-term phenomenon. That said, it is a good company for ...
- Can Gland Pharma stock see more upside?
A 17%-18% jump was a good opening and the company will benefit from the fact that it has all these good long-term contracts which ensure a ...
- Gland Pharma MD on company's prospects going ahead
We know investors are mature enough to understand our business and they will see long-term perspective, says Srinivas Sadu, MD, Gland Pharm...
- Gland Pharma lists at 14% premium over issue price
The IPO, which was sold between November 9 and 11, was subscribed 2.06 times in a three-day bidding process, with the HNI and retail quotas...
- Gland Pharma in high demand ahead of listing
Gland Pharma shares were available at a premium of Rs 20 in the grey market during the offer subscription period between Nov 9 and 11. The ...
- Stocks in the news: Gland Pharma, LVB, Vodafone Idea, Mphasis & L&T
Mphasis Consulting has acquired UK-based Datalytyx for up to 13.3 million pounds (about Rs 130.4 crore).
- Gland Pharma IPO allotment status: Here's how to check it
As per the IPO prospectus, the basis of allotment for the Gland Pharma IPO is likely on Tuesday while the refund process would be initiated...
- Gland Pharma issue subscribed 2.06 times
Gland Pharma’s initial public offer (IPO), the biggest ever offering in the Indian pharmaceutical sector — was subscribed 2.06 times on the...
- Gland Pharma’s Rs 6,480 crore IPO sails through, gets 2.06x bids
Progressive Share Brokers said that sentiment towards the IPO has dampened a bit due to Chinese investments as well as from the fact that S...
- Why is Gland Pharma citing India-China ties as key risk to IPO
The pharma company that is majority-owned by Chinese conglomerate Fosun International has noted in its filings with Sebi that it could face...
- Gland Pharma IPO receives 22% bids on Day 2
Progressive Share Brokers said the sentiment towards the IPO has dampened a bit due to Chinese investments as well as from the fact that Sa...
- Gland Pharma's Rs 6,480 crore IPO kicks off: Should you subscribe?
The Shanghai Fosun Pharma-owned company raised a total of Rs 1,943.86 crore from 70 anchor investors.
- Gland Pharma IPO off to lacklustre start, subscribed 4% on Day 1
The IPO is a mix of a fresh issue of shares worth Rs 1,250 crore and an offer for sale of up to 3.49 crore shares.
- Gland Pharma IPO: Analysts recommend subscribing, but flag stretched valuations
Gland Pharma’s IPO is India’s largest pharmaceutical IPO ever.
- Gland Pharma raises Rs 1944 crore before IPO
The IPO will open from 9 November for subscription and will close on 11 November.
- Gland Pharma raises Rs 1,944 crore from 70 anchor investors ahead of IPO
Gland Pharma has set a price band of Rs 1,490-1,500 per share for its Rs 6,500 crore IPO, which will be sold between November 9 and 11.
- Grey market premium fizzles out for Gland Pharma after fixing price band
The Gland Pharma IPO, India’s largest from the pharmaceutical sector, comprises a fresh issue aggregating up to Rs 1,250 crore and an offer...
- Gland Pharma IPO to open on Nov 9; price band fixed at Rs 1,490-1,500 per share
The Gland Pharma IPO, India’s largest IPO in the pharmaceutical sector, comprises a fresh issue aggregating up to Rs 1,250 crore and an off...
MORE NEWS
